Radio
Now Playing
Quickyla Radio — Click to play
Open →
Radio
Now Playing Quickyla Radio — Click to play
Open Radio →
Breaking
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegov…Thursday 8/6 Insider Buying Report: PFE, GBFHPfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its…Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Weight Loss D…

Choose Language

Select a language for news translation.

Results for "Pfizer" 6 articles

No stories found

New articles are fetched every 25 minutes. Refresh

Markets
S&P 5005,432.18▲ 0.42%
NASDAQ17,891.40▲ 0.87%
DOW39,118.86▼ 0.15%
BTC$67,842▲ 2.14%
ETH$3,291▲ 1.38%
GOLD$2,341/oz▼ 0.31%
OIL (WTI)$82.14▲ 0.67%
EUR/USD1.0842▼ 0.09%
GBP/USD1.2641▲ 0.22%
NIKKEI38,471▲ 1.02%
FTSE 1008,218▼ 0.28%
Full Markets →
Local Weather
—°F
Local area
58% 12 mphH:78° L:61°
Emergency Alerts
{# These used to be hardcoded, permanently-displayed example alerts ("Wildfire Warning... until 8PM") with no real data source — that's fabricated safety information shown to every visitor regardless of actual conditions. Removed rather than left live; a real version needs a genuine feed (e.g. the free NWS alerts API) behind it. #}
No active alerts for your area right now.
✦ AI Powered
Summarize any article instantly
Get 30-second summaries, bullet points, deep analysis, or a child-friendly version — powered by AI.
30-sec summary Bullet points Deep analysis
✦ Based on Your Interests
Trending stories you might like
Sign in to personalize
Around the World
▶ Video News
📈 Markets & Finance
2 days ago
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound
Nasdaq News · ▶ Watch
📈 Markets & Finance
3 days ago
Pfizer director and Gbank CEO invest $1.7 million in company shares
Nasdaq News · ▶ Watch
📈 Markets & Finance
5 days ago
Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis, other drugs
CNBC Earnings · ▶ Watch
📈 Markets & Finance
6 days ago
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?
Nasdaq News · ▶ Watch
🔬 Science
7 days ago
New microscopy method achieves angstrom-scale localization precision with one laser
Phys.org · ▶ Watch
📈 Markets & Finance
9 days ago
Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Weight Loss Drug. Why Are So Many Investors Still Ignoring the Stock?
Nasdaq News · ▶ Watch
Religion & Culture More →
Islam Christianity Hinduism Judaism Sikhism Interfaith Culture

More to Read

Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks U…
📈 Markets & Finance
Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordi…
Nasdaq News · 2 days ago
Thursday 8/6 Insider Buying Report: PFE, GBFH
📈 Markets & Finance
Pfizer director and Gbank CEO invest $1.7 million in company shares
Nasdaq News · 3 days ago
Pfizer tops estimates, hikes low end of revenue guidance on…
📈 Markets & Finance
Pfizer tops estimates, hikes low end of revenue guidance on strength of Eliquis…
CNBC Earnings · 5 days ago
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is…
📈 Markets & Finance
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buyi…
Nasdaq News · 6 days ago
New microscopy method achieves angstrom-scale localization …
🔬 Science
New microscopy method achieves angstrom-scale localization precision with one l…
Phys.org · 7 days ago
Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Prom…
📈 Markets & Finance
Pfizer Yields 6.8%, Trades at 8.5X Earnings, and Has a Promising Late-Stage Wei…
Nasdaq News · 9 days ago
Full view